Omnicorder Technologies To File DAT Breast Cancer Screen 510(k) In 1999
This article was originally published in The Gray Sheet
Executive Summary
Omnicorder Technologies is planning to follow up a 1999 510(k) submission for its DAT dynamic area telethermometry breast cancer screening system as an adjunct to existing modalities with a premarket approval application seeking clearance as a stand-alone diagnostic tool, according to a recent prospectus outlining the company's 1.1 mil.-share initial public offering.